微生物与感染
2024年11月29日 星期五   首页 |  主编心语 |  期刊介绍 |  编委阵容 |  投稿指南 |  出版道德 |  期刊订阅 |  联系我们 | English
微生物与感染  2021, Vol. 16 Issue (5): 347-355    DOI: DOI:10.3969/j.issn.1673-6184.2021.05.009
  综述 本期目录 | 过刊浏览 | 高级检索 |
肠道菌群影响非酒精性脂肪性肝病的机制及应对策略
王玉栎1,刘畅1,牛辰1,吴健1,2,3
1. 复旦大学基础医学院病原生物学系,上海 200032; 2. 复旦大学附属中山医院消化科,上海 200032; 3. 复旦大学上海医学院上海市肝病研究所,上海 200032
The mechanism of intestinal dysbiosis affecting nonalcoholic fatty liver disease and its intervention strategies
WANG Yuli1, LIU Chang1, NIU Chen1, WU Jian1,2,3
1. Department of Medical Microbiology & Parasitology, MOE/NHC Key Laboratory of Medical Molecular Virology, School of Basic Medical Sciences, Fudan University Shanghai Medical College, Shanghai 200032, China; 2. Department of Gastroenterology & Hepatology, Zhongshan Hospital of Fudan University, Shanghai 200032, China; 3. Shanghai Institute of Liver Diseases, Fudan University Shanghai Medical College, Shanghai 200032, China
全文: PDF (1076 KB)   HTML (536)
输出: BibTeX | EndNote (RIS)      
摘要: 非酒精性脂肪性肝病(nonalcoholic fatty liver disease,NAFLD)的发病率逐年升高,已成为最常见的肝脏疾病之一。目前其发病机制未被完全阐明,尚无有效治疗药物。肠道菌群与人体共生,作为人体的“第二基因组”,其在消化、吸收及代谢中发挥重要作用。新近研究表明,肠道菌群已成为影响NAFLD发生、进展的重要因素,肠道菌群失调和肠肝轴紊乱与非酒精性单纯性脂肪肝(nonalcoholic fatty liver,NAFL)发展为非酒精性脂肪性肝炎(nonalcoholic steatohepatitis,NASH)、肝纤维化和肝细胞癌(hepatocellular carcinoma,HCC)密切相关。因此,肠道微生态干预有望成为预防或治疗NAFLD的新手段。本综述主要探讨肠道菌群异常对NAFLD/NASH发病过程、机制的影响及干预措施。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
王玉栎1
刘畅1
牛辰1
吴健1
2
3
关键词 非酒精性脂肪性肝病肠道菌群胆汁酸代谢菌群失调    
Abstract:Incidence of nonalcoholic fatty liver disease (NAFLD) has been increasing, and NAFLD has become one of the most common liver diseases. Its pathogenesis has not been fully elucidated, and there are no effective medications so far. As the ‘second genome’ of human body, gut microbiota plays an important role in nutrient digestion, absorption and metabolism. Growing evidence has suggested that gut dysbiosis contributes significantly to occurrence of NAFLD and is critical for progression of nonalcoholic fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH), liver fibrosis or hepatocellular carcinoma (HCC). Therefore, new strategies for gut microbiota intervention are developed to prevent or treat NAFLD. This review intends to mainly discuss the impacts of intestinal microbial abnormality on the pathogenesis, mechanism and intervention of NAFLD/NASH.
Key wordsNonalcoholic fatty liver disease    Dysbiosis    Bile acid metabolism    gut microbiota
ZTFEL:  R3  
基金资助:国家自然科学基金(81272436、81572356、81871997、82170624),国家重点研发计划项目(2016YFE0107400)
通讯作者: 吴健     E-mail: jian.wu@fudan.edu.cn
引用本文:   
王玉栎1,刘畅1,牛辰1,吴健1,2,3. 肠道菌群影响非酒精性脂肪性肝病的机制及应对策略[J]. 微生物与感染, 2021, 16(5): 347-355.
WANG Yuli1, LIU Chang1, NIU Chen1, WU Jian1,2,3. The mechanism of intestinal dysbiosis affecting nonalcoholic fatty liver disease and its intervention strategies. JOURNAL OF MICROBES AND INFECTIONS, 2021, 16(5): 347-355.
链接本文:  
http://jmi.fudan.edu.cn/CN/DOI:10.3969/j.issn.1673-6184.2021.05.009     或     http://jmi.fudan.edu.cn/CN/Y2021/V16/I5/347

版权所有 © 2008 《微生物与感染》编辑部
地址:上海市医学院路138号 邮编:200032
Tel:021-54237633 Fax:021-64434224    E-mail:jmi@fudan.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发  技术支持:support@magtech.com.cn